Entries of Holzinger, Jens on the publication server

Hüttmann, Andreas, Rekowski, Jan , Müller, Stefan P., Hertenstein, Bernd, Franzius, Christiane, Mesters, Rolf, Weckesser, Matthias, Kroschinsky, Frank, Kotzerke, Jörg, Ganser, Arnold, Bengel, Frank M. , La Rosée, Paul, Freesmeyer, Martin, Höffkes, Heinz-Gert, Hertel, Andreas, Behringer, Dirk, Prange-Krex, Gabriele, Griesshammer, Martin, Holzinger, Jens, Wilop, Stefan, Krohn, Thomas, Raghavachar, Aruna, Maschmeyer, Georg, Brink, Ingo, Schroers, Roland, Gaska, Tobias, Bernhard, Helga, Giagounidis, Aristoteles, Schütte, Jochen, Dienst, Ariane, Hautzel, Hubertus, Naumann, Ralph, Klein, Alfred, Hahn, Dennis, Pöpperl, Gabriele, Grube, Matthias, Marienhagen, Jörg, Schwarzer, Andreas, Kurch, Lars, Höhler, Thomas, Steiniger, Heike, Nückel, Holger, Südhoff, Thomas, Römer, Wolfgang, Brinkmann, Marcus, Ose, Claudia, Alashkar, Ferras, Schmitz, Christine, Dürig, Jan, Hoelzer, Dieter, Jöckel, Karl-Heinz, Klapper, Wolfram and Dührsen, Ulrich (2019) Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial. Annals of Hematology 98 (4), pp. 897-907. Fulltext not available.